The 100 million people would include all of the country’s front-line healthcare workers, the elderly and people with underlying conditions. Dr. Slaoui said he based the estimate on the number of vaccines both Moderna and Pfizer have said they can distribute by then.
If Johnson & Johnson’s vaccine candidate is authorized before February, that estimate could increase, Dr. Slaoui told The Hill. He said he expects the drugmaker to release its late-stage trial data in January.
Gen. Gustave Perna, CEO of the U.S. coronavirus-fighting effort, Operation Warp Speed, said the government will ship 6.4 million doses of Pfizer’s vaccine within 24 hours of FDA authorization and 12.5 million doses of Moderna’s in the same time period, The Hill reported.
States have until Dec. 4 to submit to the federal government their final plans for vaccine distribution.
Read the full article here.
More articles on pharmacy:
Moderna to test COVID-19 vaccine in adolescents
US to disseminate paper reminders about COVID-19 vaccine second dose
CDC panel recommends healthcare workers, nursing home residents get COVID-19 vaccine first
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
